Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 257

    1.

    Valsartan: more than a decade of experience.

    Black HR, Bailey J, Zappe D, Samuel R.

    Drugs. 2009;69(17):2393-414. doi: 10.2165/11319460-000000000-00000.PMID: 19911855 [PubMed - in process]Related articles

    2.

    The editor's roundtable: prehypertension.

    Roberts WC, Bakris GL, Black HR, Sica DA, Sulkes DJ.

    Am J Cardiol. 2009 Oct 15;104(8):1105-15. No abstract available. PMID: 19801033 [PubMed - indexed for MEDLINE]Related articles

    3.

    ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

    Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA; American College of Cardiology Foundation; American Heart Association; American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease); American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; National Lipid Association; Preventive Cardiovascular Nurses Association.

    J Am Coll Cardiol. 2009 Sep 29;54(14):1336-63. No abstract available. PMID: 19778678 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment.

    Maitland ML, Kasza KE, Karrison T, Moshier K, Sit L, Black HR, Undevia SD, Stadler WM, Elliott WJ, Ratain MJ.

    Clin Cancer Res. 2009 Oct 1;15(19):6250-7. Epub 2009 Sep 22.PMID: 19773379 [PubMed - in process]Related articles

    5.

    ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

    Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA; American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; Preventive Cardiovascular Nurses Association.

    Circulation. 2009 Sep 29;120(13):e100-26. Epub 2009 Sep 21. No abstract available. PMID: 19770387 [PubMed - indexed for MEDLINE]Related articles

    6.

    ASH Position Paper: Dietary approaches to lower blood pressure.

    Appel LJ; American Society of Hypertension Writing Group, Giles TD, Black HR, Izzo JL Jr, Materson BJ, Oparil S, Weber MA.

    J Clin Hypertens (Greenwich). 2009 Jul;11(7):358-68.PMID: 19583632 [PubMed - indexed for MEDLINE]Related articles

    7.

    Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.

    Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM.

    J Hypertens. 2009 Apr;27(4):673-9. Review.PMID: 19516168 [PubMed - indexed for MEDLINE]Related articles

    8.

    Triple fixed-dose combination therapy: back to the past.

    Black HR.

    Hypertension. 2009 Jul;54(1):19-22. Epub 2009 May 26. No abstract available. PMID: 19470871 [PubMed - indexed for MEDLINE]Related articles

    9.

    Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.

    Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN.

    Arch Intern Med. 2009 May 11;169(9):843-50.PMID: 19433695 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses.

    Wright JT Jr, Probstfield JL, Cushman WC, Pressel SL, Cutler JA, Davis BR, Einhorn PT, Rahman M, Whelton PK, Ford CE, Haywood LJ, Margolis KL, Oparil S, Black HR, Alderman MH; ALLHAT Collaborative Research Group.

    Arch Intern Med. 2009 May 11;169(9):832-42.PMID: 19433694 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evidence for a lower target blood pressure for people with heart disease.

    Rosendorff C, Black HR.

    Curr Opin Cardiol. 2009 Jul;24(4):318-24.PMID: 19395951 [PubMed - in process]Related articles

    12.

    Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.

    Lacourcière Y, Wright JT Jr, Samuel R, Zappe D, Purkayastha D, Black HR; EVALUATE study.

    Blood Press Monit. 2009 Jun;14(3):112-20.PMID: 19384192 [PubMed - indexed for MEDLINE]Related articles

    13.

    Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

    Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, Farber MA, Ford CE, Levy D, Massie BM, Nawaz S; ALLHAT Collaborative Research Group.

    Circulation. 2008 Nov 25;118(22):2259-67. Epub 2008 Nov 10.PMID: 19001024 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Challenges to the diagnosis, evaluation, treatment, and management of clustered cardiometabolic risk factors.

    Wilson PW, Black HR, Fabricatore AN, Goldberg IJ.

    J Cardiometab Syndr. 2008 Summer;3(3):177-82.PMID: 18983336 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial.

    Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, Beresford SA, Connelly SA, Curb JD, Grimm RH Jr, Kotchen TA, Kuller LH, Wassertheil-Smoller S, Thomson CA, Torner JC; Women's Health Initiative Investigators.

    Hypertension. 2008 Nov;52(5):847-55. Epub 2008 Sep 29.PMID: 18824662 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pharmacologic considerations in the positioning of beta-blockers in antihypertensive therapy.

    Sica DA, Black HR.

    Curr Hypertens Rep. 2008 Aug;10(4):330-5. Review.PMID: 18625165 [PubMed - indexed for MEDLINE]Related articles

    17.

    Secondary hypertension.

    Black HR.

    J Clin Hypertens (Greenwich). 2008 Jul;10(7):520-1. No abstract available. PMID: 18607137 [PubMed - indexed for MEDLINE]Related articles

    18.

    American Society of Hypertension, Inc.: president's message.

    Black HR.

    J Clin Hypertens (Greenwich). 2008 May;10(5):417. No abstract available. PMID: 18453804 [PubMed - indexed for MEDLINE]Related articles

    19.

    Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

    Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR.

    Arch Intern Med. 2008 Jan 28;168(2):207-17.PMID: 18227370 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

    Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT Jr, Basile J, Wong ND, Whelton P, Dart RA, Thadani U; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

    Diabetes Care. 2008 Feb;31(2):353-60. Epub 2007 Nov 13.PMID: 18000186 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study.

    Black HR, Bakris GL, Weber MA, Weiss R, Shahawy ME, Marple R, Tannoury G, Linas S, Wiens BL, Linseman JV, Roden R, Gerber MJ.

    J Clin Hypertens (Greenwich). 2007 Oct;9(10):760-9.PMID: 17917503 [PubMed - indexed for MEDLINE]Related articles

    22.

    Prehypertension.

    Elliott WJ, Black HR.

    Nat Clin Pract Cardiovasc Med. 2007 Oct;4(10):538-48. Review.PMID: 17893682 [PubMed - indexed for MEDLINE]Related articles

    23.

    The cardiometabolic syndrome and calcium channel blocker combination drugs.

    Sowers JR, Bakris GL, Black HR, Giles TD.

    J Cardiometab Syndr. 2007 Summer;2(3):207-12.PMID: 17786085 [PubMed - indexed for MEDLINE]Related articles

    24.

    Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action.

    Bakris G, Hill M, Mancia G, Steyn K, Black HR, Pickering T, De Geest S, Ruilope L, Giles TD, Morgan T, Kjeldsen S, Schiffrin EL, Coenen A, Mulrow P, Loh A, Mensah G.

    J Hum Hypertens. 2008 Jan;22(1):63-70. Epub 2007 Aug 30.PMID: 17728797 [PubMed - indexed for MEDLINE]Related articles

    25.

    The role of therapeutic inertia and the use of fixed-dose combination therapy in the management of hypertension.

    Basile J, Black HR, Flack JM, Izzo JL Jr.

    J Clin Hypertens (Greenwich). 2007 Aug;9(8):636-45. No abstract available. PMID: 17673886 [PubMed - indexed for MEDLINE]Related articles

    26.

    The editor's roundtable: revisiting the role of beta blockers in hypertension.

    Roberts WC, Black HR, Bakris GL, Mason RP, Giles TD, Sulkes DJ.

    Am J Cardiol. 2007 Jul 15;100(2):253-67. Epub 2007 Jun 6. No abstract available. PMID: 17631080 [PubMed - indexed for MEDLINE]Related articles

    27.

    Commentary on ICEBERG.

    Black HR.

    J Clin Hypertens (Greenwich). 2007 Jul;9(7):557. No abstract available. PMID: 17617767 [PubMed - indexed for MEDLINE]Related articles

    28.

    Microalbuminuria, chronic renal disease, and the effects of the metabolic syndrome on cardiovascular events.

    Moser M, Sowers JR, Black HR.

    J Clin Hypertens (Greenwich). 2007 Jul;9(7):551-6.PMID: 17617766 [PubMed - indexed for MEDLINE]Related articles

    29.

    Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention.

    Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S; American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention.

    Circulation. 2007 May 29;115(21):2761-88. Epub 2007 May 14. No abstract available. Erratum in: Circulation. 2007 Jul 31;116(5):e121.. PMID: 17502569 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.

    Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA; CHARISMA Investigators.

    J Am Coll Cardiol. 2007 May 15;49(19):1982-8. Epub 2007 Apr 11.PMID: 17498584 [PubMed - indexed for MEDLINE]Related articles

    31.

    Prehypertension and cardiovascular disease risk in the Women's Health Initiative.

    Hsia J, Margolis KL, Eaton CB, Wenger NK, Allison M, Wu L, LaCroix AZ, Black HR; Women's Health Initiative Investigators.

    Circulation. 2007 Feb 20;115(7):855-60.PMID: 17309936 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    A comparison of two sphygmomanometers that may replace the traditional mercury column in the healthcare workplace.

    Elliott WJ, Young PE, DeVivo L, Feldstein J, Black HR.

    Blood Press Monit. 2007 Feb;12(1):23-8.PMID: 17303984 [PubMed - indexed for MEDLINE]Related articles

    33.

    Improving blood pressure control rates: is there more we can do?

    Bakris GL, Weir MR, Black HR.

    J Clin Hypertens (Greenwich). 2007 Feb;9(2):134-42. No abstract available. PMID: 17268218 [PubMed - indexed for MEDLINE]Related articles

    34.

    The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.

    Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W.

    Circulation. 2006 Dec 19;114(25):2871-91. Review. No abstract available. PMID: 17179035 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).

    Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W.

    Circulation. 2006 Dec 19;114(25):2850-70. Review. No abstract available. PMID: 17179034 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.

    Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, Levy D, Nwachuku CE, Black HR; ALLHAT Collaborative Research Group.

    Am Heart J. 2007 Jan;153(1):42-53.PMID: 17174636 [PubMed - indexed for MEDLINE]Related articles

    37.

    Prehypertension--what is it and should it be treated?

    Moser M, Giles TD, Izzo JL Jr, Black HR.

    J Clin Hypertens (Greenwich). 2006 Nov;8(11):812-8. No abstract available. PMID: 17086022 [PubMed - indexed for MEDLINE]Related articles

    38.

    Expanding the definition of hypertension to incorporate global cardiovascular risk.

    Khosla N, Black HR.

    Curr Hypertens Rep. 2006 Oct;8(5):384-90. Review.PMID: 16965724 [PubMed - indexed for MEDLINE]Related articles

    39.

    Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

    Piller LB, Ford CE, Davis BR, Nwachuku C, Black HR, Oparil S, Retta TM, Probstfield JL; ALLHAT Collaborative Research Group.

    J Clin Hypertens (Greenwich). 2006 Sep;8(9):649-56; quiz 657-8.PMID: 16957427 [PubMed - indexed for MEDLINE]Related articles

    40.

    Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

    Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

    Hypertension. 2006 Sep;48(3):374-84. Epub 2006 Jul 24.PMID: 16864749 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Blood pressure reduction is not the only determinant of outcome.

    Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR, Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR.

    Circulation. 2006 Jun 13;113(23):2754-72; discussion 2773-4. No abstract available. PMID: 16769926 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Development of explicit criteria to measure adherence to hypertension guidelines.

    Milchak JL, Carter BL, Ardery G, Black HR, Bakris GL, Jones DW, Kreiter CD.

    J Hum Hypertens. 2006 Jun;20(6):426-33.PMID: 16543909 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Feasibility of treating prehypertension with an angiotensin-receptor blocker.

    Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, Black HR, Grimm RH Jr, Messerli FH, Oparil S, Schork MA; Trial of Preventing Hypertension (TROPHY) Study Investigators.

    N Engl J Med. 2006 Apr 20;354(16):1685-97. Epub 2006 Mar 14.PMID: 16537662 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

    Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ; CHARISMA Investigators.

    N Engl J Med. 2006 Apr 20;354(16):1706-17. Epub 2006 Mar 12.PMID: 16531616 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Controlled-release doxazosin as combination therapy in hypertension: the GATES study.

    Black HR, Keck M, Meredith P, Bullen K, Quinn S, Koren A.

    J Clin Hypertens (Greenwich). 2006 Mar;8(3):159-66; quiz 167-8.PMID: 16522992 [PubMed - indexed for MEDLINE]Related articles

    46.

    Calcium plus vitamin D supplementation and the risk of colorectal cancer.

    Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE; Women's Health Initiative Investigators.

    N Engl J Med. 2006 Feb 16;354(7):684-96. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102. PMID: 16481636 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Calcium plus vitamin D supplementation and the risk of fractures.

    Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women's Health Initiative Investigators.

    N Engl J Med. 2006 Feb 16;354(7):669-83. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102. PMID: 16481635 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

    Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM.

    JAMA. 2006 Feb 8;295(6):655-66.PMID: 16467234 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

    Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, Black HR, Anderson GL, Assaf AR, Bassford T, Bowen D, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Harrigan RC, Hays J, Heber D, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Kotchen JM, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lewis CE, Manson JE, Margolis KL, Mossavar-Rahmani Y, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Stefanick ML, Van Horn L, Vitolins MZ, Wactawski-Wende J, Wallace RB, Whitlock E.

    JAMA. 2006 Feb 8;295(6):643-54.PMID: 16467233 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

    Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, Paskett E, Phillips L, Robbins J, Rossouw JE, Sarto GE, Shikany JM, Stefanick ML, Thomson CA, Van Horn L, Vitolins MZ, Wactawski-Wende J, Wallace RB, Wassertheil-Smoller S, Whitlock E, Yano K, Adams-Campbell L, Anderson GL, Assaf AR, Beresford SA, Black HR, Brunner RL, Brzyski RG, Ford L, Gass M, Hays J, Heber D, Heiss G, Hendrix SL, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Kotchen JM, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Henderson MM.

    JAMA. 2006 Feb 8;295(6):629-42.PMID: 16467232 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...